Sugi Predict

Sugi Predict / Compounds / SCHEMBL3758939

SCHEMBL3758939

SCHEMBL3758939

Nc1ccn[c]c1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ MAPT P10636 3/20 0.35
▸ HSP90AA1 P07900 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ TAAR1 Q96RJ0 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ NOTUM Q6P988 1/20 0.34
▸ ADORA2A P29274 3/20 0.34
▸ ADORA1 P30542 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL435001 0.77 LRRK2 (0.39) ALDH1A1HSD17B10HPGDNOTUMTDO2
SCHEMBL3751748 0.75 BACE1 (0.38) ALDH1A1HSD17B10MAPTHSP90AA1KDM4E
SCHEMBL2399248 0.75 NOTUM (0.34) ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2
SCHEMBL3759693 0.75 CYP2A6 (0.37) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL3759980 0.75 PDE10A (0.36) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL4054896 0.71 TDO2 (0.42) ALDH1A1HSD17B10HSP90AA1LMNAALOX15
SCHEMBL3763849 0.71 MAPT (0.38) ALDH1A1HSD17B10MAPTHSP90AA1KDM4E
SCHEMBL3760100 0.71 KMT2A (0.38) ALDH1A1HSP90AA1KDM4ELMNAMEN1
SCHEMBL3763076 0.71 PDCD1 (0.38) ALDH1A1HSD17B10MAPTKDM4ELMNA
SCHEMBL3766619 0.71 CA12 (0.38) ALDH1A1HSD17B10MAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 — — EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 — — US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 — — US disclosed
WO-2009122148-A1 FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS PI3K KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-10-08 — — WO disclosed
WO-2009071895-A1 FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
WO-2009071890-A1 TRICYCLIC KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
EP-2029570-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB Pharma S.A. (BE) 2009-03-04 — — EP disclosed
WO-2007141504-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2007-12-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA ALDH1A1 3061/4885HSD17B10 2922/4885MAPT 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.